How to Tackle All 5 Discussion Questions
A 41-year-old man. Six weeks of sadness, hopelessness, insomnia, alcohol use, job abandonment, and suicidal ideation. Five rubric questions. Here’s exactly how to approach each one — DSM-5-TR diagnostic reasoning, first-line pharmacotherapy, non-pharmacological options, and a proper treatment assessment — without missing what the grader is looking for.
Five questions. One patient. And a rubric that rewards specificity — not general knowledge about depression. The case gives you everything you need to make a diagnosis, prescribe, and justify your choices. The students who score well are the ones who connect every answer directly back to the case details and cite a clinical guideline, not just a textbook paragraph. This guide walks you through exactly how to do that.
What This Guide Covers
Submission Requirements at a Glance
Before anything else, check what the post actually requires. Five questions, 500-word minimum, APA format, two academic sources. That’s your ceiling and your floor. Students who lose marks usually either miss a question entirely or treat one of the five as a throwaway paragraph.
Discussion Post Checklist
Q1: How to Summarise the Clinical Case
A case summary in a clinical context isn’t the same as copying out the scenario. It’s your clinical reading of the presentation. Think of how a clinician would document a patient — what’s relevant, what’s time-sensitive, what flags an immediate risk.
Every Detail in This Scenario Is Clinically Relevant
The age (41-year-old male), the symptom cluster (hopelessness, sadness, helplessness, unprovoked crying, insomnia), the six-week duration, functional impairment (stopped working), the increased alcohol use, and — critically — the suicidal ideation (thoughts of driving into a canal). That last one isn’t a throwaway line. It’s an active safety concern and shapes the clinical picture entirely.
Structure to follow: Patient demographics → presenting complaint → symptom duration and onset → functional impairment → risk factors → most critical clinical concern. Keep it to a paragraph or two. Objective, not dramatic.The patient disclosed suicidal thoughts (driving into a canal) only when he was alone with the clinician. This is a passive suicidal ideation disclosure — and it matters for the diagnosis, the treatment plan, and any safety assessment. Your summary should mention it. It also affects the urgency of the pharmacological and non-pharmacological plan.
Q2: Making the DSM-5-TR Diagnosis
The rubric wants a diagnosis. Not a guess. That means applying the DSM-5-TR criteria systematically to the case and showing your work. Pick the right diagnosis and the right specifiers.
Apply the Criteria, Then Rule Out the Alternatives
Work through the DSM-5-TR criteria set for the most likely diagnosis. Identify which symptoms in the case map to which criteria. Then address the differential — what rules out other depressive disorders, substance-induced mood disorder, or an adjustment disorder? The six-week duration and the severity of impairment are your key anchors here.
Specifiers matter: The diagnosis doesn’t end at the disorder name. Consider whether the presentation calls for a severity specifier (mild, moderate, severe), an episode type specifier, and — given the passive suicidal ideation — any relevant risk-related specifiers. Check the DSM-5-TR specifier list for MDD specifically.| Case Feature | Clinical Significance | Diagnostic Relevance |
|---|---|---|
| Sadness, hopelessness, helplessness | Core mood symptoms | Maps to depressed mood criterion |
| Crying for no reason | Emotional dysregulation | Supports depressed mood; anhedonia possible |
| Sleep difficulty | Neurovegetative symptom | Insomnia criterion — specify type |
| Stopped going to work | Functional impairment | Required for diagnosis: distress/impairment criterion |
| Increased alcohol use | Maladaptive coping; comorbidity risk | Rule out substance-induced mood disorder; note as risk factor |
| Suicidal ideation (canal) | Active safety risk | Supports severe specifier; informs urgency of treatment |
| 6-week onset | Duration meets minimum threshold | Consistent with MDD (≥ 2 weeks); rules out PDD at this stage |
The DSM-5-TR is the only source you should cite for your diagnostic criteria in Q2. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). Your institution’s library will have access. If you’re comparing MDD and PDD criteria, the depressive disorders criteria guide on this site breaks down the differences in detail.
Q3: Prescribing the Pharmacological Treatment
This is the question that requires the most specific detail. The rubric asks for a drug name, dose, route, frequency, and a rationale grounded in clinical guidelines. Vague answers — “an antidepressant would be appropriate” — don’t earn marks here.
Start With the APA Practice Guideline, Not the Textbook
The APA Practice Guideline for the Treatment of Patients with Major Depressive Disorder is the reference point for pharmacological treatment decisions. It specifies first-line options, dosing ranges, and the evidence base behind each class of medication. Use it directly — don’t paraphrase someone else’s paraphrase of it.
Also check: NICE Guidelines for Depression (CG90 and NG222) if your program accepts international guidelines. VA/DoD Clinical Practice Guidelines for MDD are another strong peer-reviewed source with specific prescribing protocols.What to Include in the Prescription Section
This is non-negotiable for full marks. Every element of a proper prescription needs to be present.
- Drug name — generic and brand
- Dose — starting dose and target therapeutic dose
- Route — oral is standard for outpatient first-line antidepressants
- Frequency — once daily, twice daily, etc.
- Duration — how long before reassessment
- Guideline citation — where this recommendation comes from
Writing the Rationale
The rationale has two parts: why this drug class and why this specific agent within that class. Think about:
- Why first-line over second-line for this patient
- The patient’s alcohol use — does it interact with the chosen agent?
- Safety profile given suicidal ideation — overdose risk matters here
- What the guideline says about the chosen drug’s efficacy evidence
- Tolerability vs. efficacy trade-offs
The patient is drinking more than usual. That’s not just a lifestyle note — it affects drug choice, monitoring, and the overdose risk calculation. When writing your rationale, address whether your chosen agent interacts with alcohol and whether increased alcohol use changes the risk profile for this patient. This is a detail many posts miss, and it’s exactly what separates a strong clinical answer from a generic one.
Address the Black Box Warning in Your Rationale
Any antidepressant prescribed to an adult with suicidal ideation requires you to address the FDA black box warning for antidepressants and suicidality. You don’t need to write a paragraph about it — a sentence or two is enough. But skipping it entirely signals that you missed a critical prescribing consideration. Your rationale should note it and explain how you plan to monitor for it (e.g., follow-up schedule, patient education).
Clinical note: SSRIs have a lower lethality in overdose compared to tricyclics — that’s a relevant safety consideration for a patient who has expressed suicidal ideation. This belongs in your rationale and your Q5 safety assessment.Q4: Non-Pharmacological Treatment (No Psychotherapy)
This question trips students up because they default to CBT or another therapy — and the rubric explicitly excludes psychotherapeutic modalities. Read that again. No CBT. No DBT. No interpersonal therapy. The question is asking about what else works beyond talk therapy and medication.
Think Behavioural and Somatic Interventions
The evidence base for MDD includes several non-psychotherapy, non-pharmacological interventions. Structured exercise programmes have a strong RCT evidence base for mild-to-moderate depression. Sleep hygiene protocols directly address the insomnia this patient presents with. Alcohol reduction counselling (not psychotherapy — more psychoeducation and brief intervention frameworks) addresses the maladaptive coping. For severe presentations, transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT) enter the picture.
Your task: Pick one or two that fit this patient’s specific presentation and justify them using clinical guidelines or peer-reviewed evidence. Don’t pick an intervention that doesn’t match the case — if you choose exercise, connect it to the patient’s occupational withdrawal and low energy, not just “exercise is good for mood.”Interventions Likely Relevant to This Case
- Structured aerobic exercise — evidence-based for MDD; addresses functional withdrawal
- Sleep hygiene protocol — directly targets the insomnia symptom
- Brief alcohol intervention — psychoeducation-based; addresses increased drinking
- Light therapy — evidence-based for seasonal patterns; worth ruling in or out
- TMS — if severity warrants; FDA-cleared for MDD
Writing the Rationale for Q4
Same structure as Q3: name the intervention, describe the mechanism or approach, cite the evidence. The rationale needs to explain why this intervention for this patient — not just what the intervention is. Connect the choice back to the case details. A patient who has stopped going to work and is isolating is a different clinical picture than someone who is high-functioning but mildly depressed.
Increased alcohol use isn’t just a differential diagnosis consideration — it’s something that needs to be addressed in the treatment plan. Alcohol is a CNS depressant. It will blunt the effect of any antidepressant and worsen insomnia and mood. Brief motivational intervention or a structured alcohol reduction protocol is a legitimate non-pharmacological, non-psychotherapy approach you can discuss in Q4.
Q5: The Treatment Assessment — Five Sub-Points, Not One
This is the question most posts underperform on. It has five distinct components: appropriateness, cost, effectiveness, safety, and adherence potential. Treating it as one blob of text misses the mark.
Does the Treatment Fit This Patient?
Address why the chosen medication is appropriate for a 41-year-old male with this symptom profile, alcohol use history, and suicidal ideation. Consider contraindications and patient-specific factors.
Actual Pharmacy Research Required
The rubric specifies using a local pharmacy to research cost. Use GoodRx, Costco Pharmacy, or call a local pharmacy. Compare 30-day supply costs for your chosen agent. Generic vs. brand matters here.
What Does the Evidence Say?
Cite a peer-reviewed study or meta-analysis showing the efficacy of the chosen drug for MDD. Response rates, remission rates, NNT (number needed to treat) if available. Ground it in evidence.
Side Effect Profile + Specific Risks
Common adverse effects, monitoring requirements, the overdose risk (important given suicidal ideation), interaction with alcohol, and any relevant FDA warnings for this drug class.
Will This Patient Actually Take It?
Consider the patient’s current functional state — he’s stopped going to work, withdrawn, drinking more. What barriers to adherence exist? How will you address them? Dosing frequency, side effect profile, and follow-up scheduling all affect adherence.
How to Do the Pharmacy Cost Research
The rubric says to use a local pharmacy and choose the most cost-effective option for the patient. Don’t skip this — it’s explicit. Here’s how to approach it:
- Go to GoodRx.com and search your chosen medication. Enter the dose and quantity (typically 30 tablets). Note the cash price vs. insurance price.
- Compare generic vs. brand-name cost for the same agent. Most first-line antidepressants have been off-patent for years — the generic price difference is significant.
- Note whether $4 generic programs (e.g., Walmart, Kroger pharmacy) include the medication — some SSRIs are on these formularies.
- Cite the pharmacy name and date accessed in your post. “As of [date], the 30-day generic supply of [drug] at [local pharmacy] was approximately $X.”
APA Formatting and Source Requirements
The post needs to be APA format with two academic sources minimum. In practice, you’ll need at least: the DSM-5-TR for Q2, one clinical guideline or peer-reviewed article for the pharmacological rationale (Q3), and possibly a second peer-reviewed source for the non-pharmacological intervention (Q4) or the effectiveness section of Q5.
Every Clinical Claim Needs One
Every diagnostic criterion you name, every dosing decision, every efficacy claim. If it came from a source, it needs a citation. Don’t cite at the end of a paragraph — cite at the claim.
Correct Reference Format
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
Where to Search
PsycINFO, PubMed, CINAHL (for nursing programs). Search your drug name + “major depressive disorder” + “randomized controlled trial” or “meta-analysis.” Filter for full text, peer-reviewed, last 10 years.
Two sources will meet the minimum: (1) the DSM-5-TR for your diagnostic criteria, and (2) one peer-reviewed study on your chosen antidepressant’s efficacy for MDD. A stronger post adds a third source — a clinical guideline (APA, NICE, or VA/DoD) for the prescribing recommendation in Q3. Three solid sources, all cited correctly, covers every question. For additional guidance on citation structure, see the citing sources guide on this site.
Mistakes That Get Points Deducted
Incomplete Prescription Details
Naming a drug without including dose, route, and frequency. The rubric lists all four components — leaving one out is a partial answer, not a complete one.
Write a Full Prescription
Treat Q3 like a real prescription pad. Drug name (generic + brand), starting dose, target dose, route (oral), frequency (e.g., once daily at same time), and reassessment timeline. Then the rationale cites the guideline.
Using Psychotherapy for Q4
The rubric excludes psychotherapeutic modalities. CBT, DBT, IPT, and similar approaches don’t belong in Q4. Students who write CBT for Q4 lose those marks entirely.
Pick a Somatic or Behavioural Intervention
Exercise programmes, sleep hygiene protocols, light therapy, TMS, brief alcohol intervention, or ECT for severe cases. Any of these with a peer-reviewed rationale is the right move for Q4.
Skipping the Alcohol Detail
The patient’s increased alcohol use is mentioned explicitly in the case. Ignoring it in your diagnosis, treatment plan, or safety assessment signals you’re not reading the case carefully.
Address It in Multiple Sections
Mention alcohol use in the case summary (Q1), note it as a differential consideration in Q2, address drug-alcohol interaction in Q3, target it as a non-pharm intervention in Q4, and flag the safety implications in Q5.
Generic Q5 Without Pharmacy Research
“SSRIs are cost-effective” without actual numbers or a local pharmacy reference. The rubric specifically asks you to research cost at a local pharmacy. A generic statement doesn’t satisfy that.
Actual Cost Data With a Source
Name the pharmacy, the drug, the quantity, the price, and when you checked it. Compare generic to brand. Note whether patient assistance programs or $4 generics apply. Cite the pharmacy by name in your references.
Frequently Asked Questions
Need Help With a Nursing or Psychology Case Study Post?
From clinical case studies and discussion posts to pharmacology papers and full research assignments — our nursing and psychology writing team covers graduate-level work across programs.
Psychology Assignment Help Get StartedRead the Case Twice Before You Start Writing
Every answer in this post is in the case scenario. The age, the timeline, the specific symptoms, the alcohol use, and that one detail about the canal — all of it has clinical weight. Students who lose marks aren’t usually wrong about the pharmacology. They miss what the rubric is asking for because they haven’t connected their generic knowledge back to the specific patient in front of them.
Q3 and Q5 are where you can genuinely stand out. A precise prescription with a guideline-backed rationale, and a Q5 that shows you actually called up GoodRx and looked at the generic price — that’s what “great detail” looks like. It’s not more words. It’s the right words, connected to this patient, supported by evidence.
And don’t underestimate Q4. The instruction to exclude psychotherapy trips up a lot of students. But it’s also an opportunity — if you pick an intervention that’s specific to this patient’s presentation (sleep, alcohol, functional withdrawal) and justify it from a guideline, that answer reads like it came from a clinician, not a student who Googled “depression treatment.”